Published in APMIS on April 01, 2001
Towards quantitative mRNA analysis in paraffin-embedded tissues using real-time reverse transcriptase-polymerase chain reaction: a methodological study on lymph nodes from melanoma patients. J Mol Diagn (2003) 2.41
Global demethylation of rat chondrosarcoma cells after treatment with 5-aza-2'-deoxycytidine results in increased tumorigenicity. PLoS One (2009) 0.95
Fluid shear promotes chondrosarcoma cell invasion by activating matrix metalloproteinase 12 via IGF-2 and VEGF signaling pathways. Oncogene (2014) 0.90
Establishment and characterization of the permanent human cell line C3842 derived from a secondary chondrosarcoma in Ollier's disease. Virchows Arch (2005) 0.87
Microenvironment alters epigenetic and gene expression profiles in Swarm rat chondrosarcoma tumors. BMC Cancer (2010) 0.86
By activating matrix metalloproteinase-7, shear stress promotes chondrosarcoma cell motility, invasion and lung colonization. Oncotarget (2015) 0.85
Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J (1999) 4.85
Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet (2000) 3.39
Predisposition to familial osteoarthrosis linked to type II collagen gene. Lancet (1989) 2.43
Localization of types I, II, and III collagen mRNAs in developing human skeletal tissues by in situ hybridization. J Cell Biol (1987) 2.41
Alveolar soft part sarcoma. Immunohistochemical evidence for muscle cell differentiation. Am J Clin Pathol (1990) 2.19
Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice. Matrix Biol (1994) 2.12
Matrix metalloproteinases in wound repair (review). Int J Mol Med (2000) 1.98
Skin strain patterns provide kinaesthetic information to the human central nervous system. J Physiol (1995) 1.85
Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res (1998) 1.83
Pigmented primitive neuroectodermal tumor with multipotential differentiation in cerebellum (pigmented medullomyoblastoma). A case with light- and electron-microscopic, and immunohistochemical analysis. Pediatr Neurosci (1987) 1.78
A standardized experimental fracture in the mouse tibia. J Orthop Res (1993) 1.75
Lisfranc joint injuries: trauma mechanisms and associated injuries. J Trauma (1993) 1.73
Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. Biochim Biophys Acta (1991) 1.67
Mouse type II collagen gene. Complete nucleotide sequence, exon structure, and alternative splicing. J Biol Chem (1991) 1.67
Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci (2000) 1.66
Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol (1997) 1.66
Integrin alpha2beta1 mediates isoform-specific activation of p38 and upregulation of collagen gene transcription by a mechanism involving the alpha2 cytoplasmic tail. J Cell Biol (1999) 1.65
Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol (1997) 1.56
Integrin alpha 2 beta 1 is a positive regulator of collagenase (MMP-1) and collagen alpha 1(I) gene expression. J Biol Chem (1995) 1.56
Bone bank service in Finland. Experience of bacteriologic, serologic and clinical results of the Turku Bone Bank 1972-1995. Acta Orthop Scand (1998) 1.56
Stage-and tissue-specific expression of a Col2a1-Cre fusion gene in transgenic mice. Matrix Biol (2001) 1.55
Surgical management of radiation-associated cutaneous breast angiosarcoma. J Plast Reconstr Aesthet Surg (2011) 1.51
Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J Cell Sci (2000) 1.50
Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J Biol Chem (1998) 1.49
Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn (1997) 1.44
p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression. Mol Cell Biol (2001) 1.43
MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J Biol Chem (2001) 1.41
Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene. Proc Natl Acad Sci U S A (1991) 1.37
Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J Biol Chem (1999) 1.37
Construction and partial characterization of two recombinant cDNA clones for procollagen from chicken cartilage. Nucleic Acids Res (1982) 1.35
Coordinated regulation of type I and type III collagen production and mRNA levels of pro alpha 1(I) and pro alpha 2(I) collagen in cultured morphea fibroblasts. Arch Dermatol Res (1987) 1.35
Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem (1996) 1.35
Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol (1997) 1.34
Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res (1995) 1.34
Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem (1999) 1.30
The mouse collagen X gene: complete nucleotide sequence, exon structure and expression pattern. Biochem J (1993) 1.28
Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas. Cancer Res (1994) 1.28
Heat shock element architecture is an important determinant in the temperature and transactivation domain requirements for heat shock transcription factor. Mol Cell Biol (1998) 1.28
Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer (2009) 1.26
Normal long bone growth and development in type X collagen-null mice. Nat Genet (1994) 1.26
Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol (1997) 1.26
Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol (1996) 1.25
Interleukin-1 increases collagen production and mRNA levels in cultured skin fibroblasts. Biochim Biophys Acta (1987) 1.25
DNA copy number amplification profiling of human neoplasms. Oncogene (2006) 1.25
Enhanced expression of TGF-beta and c-fos mRNAs in the growth plates of developing human long bones. Development (1988) 1.25
Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer. Br J Cancer (2012) 1.24
Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. J Invest Dermatol (1988) 1.21
A metaphyseal defect model of the femur for studies of murine bone healing. Bone (2001) 1.19
Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development. FEBS Lett (1996) 1.18
Cytogenetic study of 249 consecutive patients examined for a bone tumor. Cancer Genet Cytogenet (1993) 1.16
Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain. J Cell Biol (1992) 1.16
DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma. Int J Cancer (1999) 1.15
Localization of the expression of types I, III, and IV collagen, TGF-beta 1 and c-fos genes in developing human calvarial bones. Dev Biol (1988) 1.15
Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization. Br J Cancer (1997) 1.14
Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor alpha and transforming growth factor beta. Cell Growth Differ (1997) 1.12
The effect of rigidity on fracture healing in external fixation. Clin Orthop Relat Res (1989) 1.12
Synovial fluid leukocytosis in bacterial arthritis vs. reactive arthritis and rheumatoid arthritis in the adult knee. Scand J Rheumatol (1992) 1.11
Characterization of trimethoprim resistance by use of probes specific for transposon Tn7. Antimicrob Agents Chemother (1984) 1.10
Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol (1999) 1.10
Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci U S A (1996) 1.10
Lymphocyte homing receptors and adhesion molecules in intravascular malignant lymphomatosis. Int J Cancer (1989) 1.10
Evaluation of transforming growth factor beta and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization. J Invest Dermatol (1990) 1.09
Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder. Int J Cancer (2000) 1.08
Construction of a human pro alpha 1(III) collagen cDNA clone and localization of type III collagen expression in human fetal tissues. Matrix (1989) 1.08
Stress fracture of the ulnar diaphysis in a recreational golfer. Clin J Sport Med (1997) 1.08
Pore diameter of more than 100 microm is not requisite for bone ingrowth in rabbits. J Biomed Mater Res (2001) 1.08
Osteosarcoma of the bones of the foot--an easily misdiagnosed malignant tumor. Mayo Clin Proc (1998) 1.08
Soft tissue sarcoma of the trunk and extremities. Scand J Surg (2003) 1.06
Developmental expression of a type II collagen/beta-galactosidase fusion gene in transgenic mice. Dev Dyn (1995) 1.06
Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis. Am J Pathol (2001) 1.06
A role for decorin in the structural organization of periodontal ligament. Lab Invest (2000) 1.06
Role of cathepsin K in normal joints and in the development of arthritis. Curr Drug Targets (2007) 1.06
Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene (1997) 1.06
Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K. J Bone Miner Res (2001) 1.05
Merkel cell carcinoma: a clinicopathological study of 34 patients. Eur J Surg Oncol (2003) 1.05
Comparative effects of interleukin-1 and tumor necrosis factor-alpha on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J Invest Dermatol (1991) 1.05
Human pro alpha 1(I) collagen: cDNA sequence for the C-propeptide domain. Nucleic Acids Res (1988) 1.04
Localization of type I and III collagen and fibronectin production in injured gastrocnemius muscle. Lab Invest (1991) 1.04
Expression of Sox9 and type IIA procollagen during attempted repair of articular cartilage damage in a transgenic mouse model of osteoarthritis. Arthritis Rheum (2001) 1.03
Assembly of cartilage collagen fibrils is disrupted by overexpression of normal type II collagen in transgenic mice. Proc Natl Acad Sci U S A (1993) 1.02
Chondrosarcoma in a family with multiple hereditary exostoses. J Bone Joint Surg Br (2000) 1.02
Histomorphometric and molecular biologic comparison of bioactive glass granules and autogenous bone grafts in augmentation of bone defect healing. J Biomed Mater Res (1997) 1.01
Increased type I collagen mRNA levels in cultured scleroderma fibroblasts. Biochim Biophys Acta (1984) 1.01
Identification of messenger RNA for human type II collagen. FEBS Lett (1984) 1.01
Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. J Invest Dermatol (2000) 1.01
Analysis of aggrecan and tenascin gene expression in mouse skeletal tissues by northern and in situ hybridization using species specific cDNA probes. Biochim Biophys Acta (1994) 1.01